secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0000885725-24-000014
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific appoints Jonathan Monson as SVP Investor Relations; Emily Woodworth as CAO
--------------------------------------------------------------------------------

- Jonathan Monson appointed SVP Investor Relations effective March 1, 2024; will no longer serve as Chief Accounting Officer.
- Emily Woodworth (Collins) appointed SVP Global Controller and CAO effective March 1, 2024; previously VP Finance and Controller of Urology business.
- Woodworth will receive base salary, annual bonus, and incentive stock awards commensurate with officer level.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/0000885725-24-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000014/bsx-20240126.htm
  HTML page:      https://secwatch.observer/filing/0000885725-24-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer